Charles River Labs (CRL) Guides FY13 EPS Below Views

Go back to Charles River Labs (CRL) Guides FY13 EPS Below Views

JPMorgan Upgrades Charles River Labs (CRL) to Overweight

December 13, 2012 7:26 AM EST

JPMorgan upgraded Charles River Labs (NYSE: CRL) from to Overweight with a price target of $42.00 (from $40.00).

NOTE: This is the second upgrade of CRL today and follows yesterday's 9% sell-off on 2013 guidance.

For an analyst ratings summary and ratings... More

Wells Fargo Upgrades Charles River Labs (CRL) to Outperform on Major Sell-Off

December 13, 2012 7:01 AM EST

Wells Fargo upgraded Charles River Labs (NYSE: CRL) from Market Perform to Outperform with a valuation range of $40-$42, saying shares are oversold following Wednesday's 9% swoon on guidance.

The firm comments, "We are upgrading shares of CRL to Outperform from Market Perform following the company's 2013... More